Menu
Home
Products
Specialties
Services
Contact Janssen
Login
Choose your language
Menu
Products
Specialties
Services
Contact Janssen
Choose your language
This year on EHA, we shared exciting new data on Imbruvica
®
(ibrutinib) in RESONATE-2
Services
Media Center
It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
Manage cookie settings
Watch professor Ghia reveal how results from up to 7 years of follow-up reinforce the ground-breaking advance in 1L CLL that Imbruvica represents.
[1]
Categories / tags
Imbruvica
See all related
CP-240988 - June 2021